These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5436785)

  • 1. [Histogenesis of hepatic cancerous cirrhosis].
    Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1970 Jan; 30(1):3-10. PubMed ID: 5436785
    [No Abstract]   [Full Text] [Related]  

  • 2. Precancerous changes in the human liver.
    Anthony PP
    J Toxicol Environ Health; 1979; 5(2-3):301-13. PubMed ID: 224200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current approach to hepatic carcinogenesis. From cirrhosis to hepatocellular carcinoma].
    Le Bail B; Bioulac-Sage P; Tran van Nhieu J; Zafrani ES
    Ann Pathol; 1995; 15(5):332-47. PubMed ID: 8540919
    [No Abstract]   [Full Text] [Related]  

  • 4. Large cell dysplasia of hepatocytes, is it a premalignant condition?
    Kovács L; Elek G
    Acta Morphol Hung; 1987; 35(1-2):47-57. PubMed ID: 3124508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.
    Kuper H; Ye W; Broomé U; Romelsjö A; Mucci LA; Ekbom A; Adami HO; Trichopoulos D; Nyrén O
    Hepatology; 2001 Oct; 34(4 Pt 1):714-8. PubMed ID: 11584367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appearance of fibronectin in putative preneoplastic lesions and in hepatocellular carcinoma during chemical hepatocarcinogenesis in rats and in human hepatomas.
    Szendröi M; Lapis K; Zalatnai A; Robert L; Labat-Robert J
    J Exp Pathol; 1984; 1(3):189-99. PubMed ID: 6100983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
    Torbenson M; Yeh MM; Abraham SC
    Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multidisciplinary management of gastrointestinal cancer. The diagnostic and therapeutic approach for primary solid liver tumours in adults.
    Verslype C; Libbrecht L
    Best Pract Res Clin Gastroenterol; 2007; 21(6):983-96. PubMed ID: 18070699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary carcinoma of the liver: importance of paraneoplasic signs].
    Pomato AT; Zeilicoff R; Ayus J
    Prensa Med Argent; 1970 May; 57(10):484-91. PubMed ID: 4318040
    [No Abstract]   [Full Text] [Related]  

  • 12. A liver with three separate lesions.
    Sohi S; Jakate S; Ahn J
    Liver Int; 2008 Sep; 28(8):1140. PubMed ID: 18783550
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative study of cirrhosis with and without primary cancer of the liver (author's transl)].
    Gislon J; Barge J; Feldmann G
    Arch Fr Mal App Dig; 1976; 65(5):369-78. PubMed ID: 1008653
    [No Abstract]   [Full Text] [Related]  

  • 14. Bile duct adenomatosis of the liver: a misleading finding on surgical exploration of the abdomen.
    Levin SE; Dail DH; Saik RP
    Am Surg; 1975 Feb; 41(2):106-8. PubMed ID: 1122059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T; Hoso M; Nakanuma Y
    Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis.
    Inaba K; Suzuki S; Sakaguchi T; Kobayasi Y; Takehara Y; Miura K; Baba S; Nakamura S; Konno H
    J Hepatobiliary Pancreat Surg; 2007; 14(2):204-9. PubMed ID: 17384916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver cell dysplasia: a premalignant condition.
    Anthony PP
    J Pathol; 1973 Jan; 109(1):Pxvii. PubMed ID: 4719769
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of clinical correlated factors of primary carcinoma of the liver with and without cirrhosis].
    Sun XW; Tan WT; Tan S; Dan YJ; Wang SS; Deng GH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):793-4. PubMed ID: 22423370
    [No Abstract]   [Full Text] [Related]  

  • 19. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
    Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant liver tumor of complex histogenesis: mixed hepatoblastoma, hepatocellular and cholangiocellular cancer and apudoma].
    Serezhin BS; Paĭkova LV
    Arkh Patol; 1984; 46(8):63-7. PubMed ID: 6093746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.